JPMorgan Upgrades Intel to Neutral After a Brutal Selloff

Sometimes Wall Street's most telling upgrades are the grudging ones. Barron's reported that Intel shares rose 5.9% to $95.18 on Monday after JPMorgan upgraded the chipmaker to Neutral — not Buy, not even close to Buy — from its previous Underperform/Underweight stance, while maintaining its $85 price target. Analyst Harlan Sur's reasoning, as Barron's described it, was essentially that after a fall of more than 14% last week, the risk and reward in the stock finally look more balanced near that target. In analyst language, that is less a love letter than a white flag: the easy money on the short side has been made, and JPMorgan is stepping out of the way.

The premarket action had hinted at the move. TheStreet reported that Intel rose about 4% in premarket trading on the upgrade, with the $85 price target unchanged. By the time the regular session was underway, Barron's put the gain at 5.9% to $95.18 — a notably warm reception for a rating that, on paper, merely says the bank no longer expects the stock to underperform. That reaction tells you something about how beaten down sentiment around Intel had become: when expectations are low enough, the idea that Intel is not terrible anymore trades like good news.

How brutal was last week?

Brutal enough to have its own arithmetic. Mondeum reported that Intel lost $78.5 billion in market value last week alone, and that the stock now sits 37% below its June 30 close of $142.35. Pause on those two numbers for a second. A company does not shed $78.5 billion in five sessions because of one bad headline; it sheds that kind of value when investors collectively decide a story they believed in June needs to be repriced from the ground up. The distance from $142.35 to the mid-$90s is the distance between a working turnaround and a demand to prove it — and Intel, once again, finds itself in prove-it territory, a place it knows uncomfortably well.

The broader analyst map shows just how divided the Street remains. Mondeum, citing FactSet data, reported that the average price target across 52 firms sits at $120.10 — well above both JPMorgan's $85 target and Monday's $95.18 print — with 16 firms rating Intel a Buy, 28 a Hold, and just 1 a Sell. That distribution is fascinating: almost nobody wants to sell it, a solid minority wants to buy it, and the great mass of the analyst community is parked at Hold, waiting. JPMorgan's move from the bearish camp into the neutral camp fits that picture perfectly. The bears are quietly leaving the room; the bulls have not yet taken it over.

The case JPMorgan actually made

It would be a mistake to read the upgrade as pure valuation surrender, because there was a fundamental thread in it too. Seeking Alpha reported that JPMorgan cited improved execution under CEO Lip-Bu Tan and growing agentic AI workloads — the kind of AI work that leans heavily on CPUs rather than only on graphics processors — as support for Intel's earnings through 2027. That second point is the interesting one for Intel shareholders. The AI boom's first chapter belonged overwhelmingly to GPUs, a market Nvidia dominates. But agentic AI — software agents that plan, reason and execute multi-step tasks — is comparatively CPU-intensive, and CPUs are Intel's home turf. If that workload shift is real and durable, Intel does not need to beat Nvidia at its own game to benefit from AI spending; it needs the spending mix to broaden, which is a much more achievable ask.

The execution point under Lip-Bu Tan matters for the same reason. Intel's problems in recent years were never only about product roadmaps; they were about credibility — missed timelines, shifting strategies, and a sense that the company announced better than it delivered. An upgrade note that explicitly credits improved execution, as Seeking Alpha reported JPMorgan's did, is the kind of sentence that would have been hard to write about Intel not long ago. It does not fix the foundry question, the balance sheet, or the competitive gap overnight. It does suggest the new leadership is registering with the analysts who grade this company hardest.

The rest of the analyst tape was busy too

Intel was not the only name getting re-rated on Monday, and the company it kept is instructive. Barron's also reported that Goldman Sachs upgraded CoreWeave to Buy — though with a price target trimmed to $106 from $139, a combination that amounts to liking the stock here, after the fall — and that Amazon rose 2.5% to $256.22 after Morgan Stanley raised its Amazon price target to $350 from $335 and named the stock a top pick. Read together, Monday's analyst actions sketch a market in triage mode after a sharp selloff: trim the targets where the story got ahead of itself, upgrade the ratings where the price has already done the punishing, and concentrate conviction in the biggest, most liquid winners like Amazon.

So what is Intel now, at $95.18 with an $85 JPMorgan target, a $120.10 consensus target, and a stock still 37% below where it closed June? Honestly, it is what JPMorgan says it is: balanced. The upgrade reported by Barron's and TheStreet is not a starting gun for bulls, and Mondeum's numbers show the carnage that made it possible, while Seeking Alpha's account of the reasoning gives the bulls something real to hold onto — execution, a CEO being credited for it, and a plausible AI angle that plays to Intel's actual strengths. For a stock that spent last week in freefall, balanced is a genuine improvement. Intel has had worse Mondays. It has also earned its skeptics, and one neutral upgrade does not retire them — it just tells you the selling, for now, may have run its course.